SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-001980
Filing Date
2021-01-05
Accepted
2021-01-05 16:31:57
Documents
13
Period of Report
2020-12-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d105716d8k.htm   iXBRL 8-K 25518
2 EX-10.1 d105716dex101.htm EX-10.1 84559
  Complete submission text file 0001193125-21-001980.txt   261265

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA acet-20201230.xsd EX-101.SCH 3071
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE acet-20201230_lab.xml EX-101.LAB 18886
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acet-20201230_pre.xml EX-101.PRE 11860
6 EXTRACTED XBRL INSTANCE DOCUMENT d105716d8k_htm.xml XML 3468
Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 21506089
SIC: 2834 Pharmaceutical Preparations